ICLR:NASDAQ
ICON PLC
$146.00
arrow_upward
+1.91%(+2.73) 1D
$146.00
0.00% (0.00)
bedtimeAfter hours
Closed: Jun 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICLR...
Open
$145.32
High
$146.51
Low
$141.70
Mkt. cap
11.18B
Avg. vol.
1.07M
Volume
870.05K
P/E ratio
50.27
52-wk high
$211.00
52-wk low
$66.58
EPS
$2.90
Beta
1.26
Shares outstanding
76.57M
No. of employees
40K
Open
$145.32
High
$146.51
Low
$141.70
Mkt. cap
11.18B
Avg. vol.
1.07M
Volume
870.05K
P/E ratio
50.27
52-wk high
$211.00
52-wk low
$66.58
EPS
$2.90
Beta
1.26
Shares outstanding
76.57M
No. of employees
40K
Analyst outlook
Analyst Ratings
Based on 13 analysts giving stock ratings to ICLR in the past 3 months
Buy
Buy
6
Hold
6
Sell
1
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for ICLR in the last 3 months.
Highest
Current $146.00
$180.00 (+23.29%)
Average
$147.55 (+1.06%)
Lowest
$125.00 (-14.38%)
News stories
From sources across the web
TradingView
·
1 day ago
ICON Schedules First Quarter 2026 Earnings Conference Call
Simply Wall Street
·
1 day ago
ICON (ICLR) Stock Could Be 15% Overvalued After Revenue Recognition Review Sell Off
DirectorsTalk Interviews
·
3 days ago
ICON Plc (ICLR) Stock Analysis: Navigating Growth With Strategic Clinical Innovations
Profile
Icon plc is an Irish-headquartered multinational clinical research organisation. Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress.
As of December 2025 Icon had approximately 40,100 employees in 55 countries. Wikipedia
About ICON PLC
AI content may include mistakes. Learn more